DNMT3B and Alzheimer disease: It was found that the DNMT3A transcript level increased two-fold both in the skin and blood samples of AD patients, whereas the transcript level of DNMT3B decreased four-fold in both skin tissue and blood samples of AD patients compared to the control group.